"DNA-Cytosine Methylases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methylases that are specific for CYTOSINE residues found on DNA.
| Descriptor ID |
D015257
|
| MeSH Number(s) |
D08.811.913.555.500.350.100
|
| Concept/Terms |
DNA-Cytosine Methylases- DNA-Cytosine Methylases
- DNA Cytosine Methylases
- Cytosine-Specific DNA Methylases
- Cytosine Specific DNA Methylases
- DNA Methylases, Cytosine-Specific
- Methylases, Cytosine-Specific DNA
Site-Specific DNA Methyltransferase (Cytosine-Specific)- Site-Specific DNA Methyltransferase (Cytosine-Specific)
- DNA Modification Methylases Cytosine Specific
- Site-Specific Methyltransferases (Cytosine-Specific)
- Modification Methylases (Cytosine-Specific)
- Site Specific Methyltransferases (Cytosine Specific)
- DNA Modification Methylases (Cytosine-Specific)
- Modification Methylases (Cytosine Specific)
|
Below are MeSH descriptors whose meaning is more general than "DNA-Cytosine Methylases".
Below are MeSH descriptors whose meaning is more specific than "DNA-Cytosine Methylases".
This graph shows the total number of publications written about "DNA-Cytosine Methylases" by people in this website by year, and whether "DNA-Cytosine Methylases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA-Cytosine Methylases" by people in Profiles.
-
Biochemical and structural characterization of the first-discovered metazoan DNA cytosine-N4 methyltransferase from the bdelloid rotifer Adineta vaga. J Biol Chem. 2023 08; 299(8):105017.
-
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood. 2020 08 06; 136(6):674-683.
-
Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients. Clin Cancer Res. 2012 Jan 15; 18(2):585-92.
-
Analysis of individual remodeled nucleosomes reveals decreased histone-DNA contacts created by hSWI/SNF. Nucleic Acids Res. 2009 Sep; 37(16):5279-94.
-
Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men. J Urol. 2006 Feb; 175(2):523-7.
-
N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell. 2003 Sep; 12(3):723-34.
-
Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation. Hum Mol Genet. 2003 Aug 01; 12(15):1791-800.
-
A new method for determining the stereochemistry of DNA cleavage reactions: application to the SfiI and HpaII restriction endonucleases and to the MuA transposase. Biochemistry. 1999 Apr 06; 38(14):4640-8.
-
Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem. 1998 Aug-Sep; 379(8-9):1113-20.
-
Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. J Immunol. 1997 Aug 01; 159(3):1303-9.